中基健康(000972) - 2024 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2024 was ¥119,254,852.12, a decrease of 20.49% compared to ¥149,986,679.55 in the same period last year[3] - Net profit attributable to shareholders was ¥5,982,705.03, down 64.56% from ¥16,882,477.46 year-on-year[3] - Basic and diluted earnings per share were both ¥0.0078, a decrease of 64.38% from ¥0.0219 in the same period last year[3] - Net profit for Q1 2024 was CNY 6,179,766.79, a decline of 63.4% from CNY 16,854,769.66 in Q1 2023[17] - Earnings per share (EPS) for Q1 2024 was CNY 0.0078, down from CNY 0.0219 in the previous year[17] Cash Flow - The net cash flow from operating activities was ¥15,146,638.30, reflecting a decline of 76.11% compared to ¥63,401,042.48 in the previous year[3] - The net cash flow from operating activities for Q1 2024 was ¥15,146,638.30, a decrease of 76.16% compared to ¥63,401,042.48 in Q1 2023[19] - Total cash inflow from operating activities was ¥122,031,810.98, while total cash outflow was ¥106,885,172.68, resulting in a net cash inflow[19] - The net cash flow from investing activities was -¥10,334,868.49, compared to -¥9,380,886.34 in the previous year, indicating increased investment outflows[19] - Cash inflow from financing activities was ¥13,941,176.66, while cash outflow was ¥87,854,459.37, leading to a net cash outflow of -¥73,913,282.71[19] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,109,460,755.88, down 9.36% from ¥1,224,071,923.98 at the end of the previous year[3] - Total liabilities amounted to CNY 893,880,363.94, a decrease from CNY 1,014,615,925.64 year-over-year[17] - Total current liabilities decreased from 923,755,080.90 to 803,501,138.24, a reduction of approximately 13%[14] - The company has a total of 437,639,298.96 in non-current assets, slightly down from 442,201,533.89[14] Shareholder Information - Total number of common shareholders at the end of the reporting period is 40,562[10] - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets, holds 16.18% of shares, totaling 124,769,223 shares[10] Expenses - The company reported a 44.93% increase in financial expenses, totaling ¥5,389,520.34, mainly due to increased borrowing costs[7] - The company has seen a significant increase in financial expenses, with interest expenses rising to CNY 6,335,081.78 from CNY 3,765,710.96 year-over-year[16] - Cash paid to employees increased to ¥19,252,747.66 in Q1 2024, compared to ¥13,837,544.16 in Q1 2023, reflecting a 39.5% increase[19] - The cash paid for taxes in Q1 2024 was ¥2,021,875.81, a decrease from ¥25,085,546.68 in Q1 2023, indicating a significant reduction in tax liabilities[19] Investments and Development - Research and development expenses amounted to ¥352,972.67, reflecting the company's ongoing investment in innovation[7] - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[3] - The company plans to focus on new product development and market expansion strategies in the upcoming quarters[17] Asset Management - The company recorded a gain of ¥783,776.41 from the disposal of fixed assets, indicating successful asset management[7] - The company reported cash inflow from the disposal of fixed assets of ¥927,700.00 in Q1 2024, with no comparable figure from the previous year[19] Other Financial Metrics - The company's cash and cash equivalents decreased by 64.26% to ¥39,545,019.03, primarily due to loan repayments[7] - The company's cash and cash equivalents decreased from 110,645,972.76 to 39,545,019.03, a decline of approximately 64.3%[13] - Accounts receivable increased from 32,695,348.41 to 40,359,003.99, representing a growth of about 23.5%[13] - Inventory decreased from 616,393,405.72 to 550,582,218.97, a reduction of approximately 10.6%[13] - The total equity attributable to shareholders of the parent company was CNY 209,469,286.27, an increase from CNY 203,541,954.43 in the previous year[17] - The company reported a credit impairment loss of CNY -857,394.97, compared to a gain of CNY 1,465,894.36 in the previous year[17] - The impact of exchange rate changes on cash and cash equivalents was minimal, with a change of ¥0.25 in Q1 2024 compared to -¥23.98 in Q1 2023[19] - Total operating revenue for Q1 2024 was CNY 119,254,852.12, a decrease of 20.5% compared to CNY 149,986,679.55 in the same period last year[16] - Total operating costs decreased to CNY 113,703,122.68, down 15.5% from CNY 134,587,988.45 year-over-year[16]